TickerFacts.

Neogen Corp (NEOG): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$94.70M
Year ended 2026-05-31
-9.1%
3-year compound annual growth
-0.1%
5-year compound annual growth
+3.3%
10-year compound annual growth
$175.30M2010-05-31: $31.31M2011-05-31: $41.16M2012-05-31: $39.91M2013-05-31: $48.12M2014-05-31: $52.57M2015-05-31: $63.77M2016-05-31: $68.57M2017-05-31: $79.64M2018-05-31: $87.25M2019-05-31: $85.72M2020-05-31: $85.92M2021-05-31: $95.21M2022-05-31: $82.31M2023-05-31: $125.89M2024-05-31: $175.30M2025-05-31: -$941.50M2026-05-31: $94.70M$94.70M
2010-05-31 EBITDA (USD) 2026-05-31
Period endedEBITDAChange YoYSource filing
2026-05-31$94.70Mn/m2026-07-30, From 2025-06-01
2025-05-31-$941.50Mn/m2026-07-30, From 2024-06-01
2024-05-31$175.30M+39.2%2026-07-30, From 2023-06-01
2023-05-31$125.89M+52.9%2025-07-30, From 2022-06-01
2022-05-31$82.31M-13.5%2024-07-30, From 2021-06-01
2021-05-31$95.21M+10.8%2023-08-15, From 2020-06-01
2020-05-31$85.92M+0.2%2022-07-27, From 2019-06-01
2019-05-31$85.72M-1.8%2021-07-30, From 2018-06-01
2018-05-31$87.25M+9.6%2020-07-30, From 2017-06-01
2017-05-31$79.64M+16.1%2019-07-30, From 2016-06-01
2016-05-31$68.57M+7.5%2018-07-27, From 2015-06-01
2015-05-31$63.77M+21.3%2017-07-28, From 2014-06-01
2014-05-31$52.57M+9.3%2016-07-29, From 2013-06-01
2013-05-31$48.12M+20.6%2015-07-30, From 2012-06-01
2012-05-31$39.91M-3.0%2014-07-30, From 2011-06-01
2011-05-31$41.16M+31.5%2013-07-30, From 2010-06-01
2010-05-31$31.31Mn/a2012-07-30, From 2009-06-01

EBITDA at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Neogen Corp (NEOG)2026-05-31$94.70Mn/m
Myriad Genetics Inc (MYGN)2025-12-31-$333.50Mn/m
Lantheus Holdings, Inc. (LNTH)2025-12-31$380.93M-27.0%
QuidelOrtho Corp (QDEL)2025-12-28-$477.20Mn/m
Idexx Laboratories Inc (IDXX)2025-12-31$1.51B+19.6%
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$431.22Mn/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$10.63Mn/m
Immucell Corp (ICCC)2025-12-31$4.43M+306.8%
Aspira Women's Health Inc. (AWHL)2025-12-31-$7.80Mn/m

Compare NEOG, MYGN, LNTH, QDEL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗